HEXAGONFAB LIMITED

Active Cambridge
14 employees website.com
Life sciences and medical technology
H

HEXAGONFAB LIMITED

Founded 11 Dec 2017 Active Cambridge, United Kingdom 14 employees website.com
Life sciences and medical technology
Accounts Submitted 8 May 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 29 Dec 2025 Next due 24 Dec 2026 8 months remaining
Net assets £3M £2M 2024 year on year
Total assets £3M £2M 2024 year on year
Total Liabilities £115K £31K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton Cambridge Cambridgeshire CB3 0QH United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for HEXAGONFAB LIMITED (11106423), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 11 Dec 2017. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£2.52M

Increased by £2.14M (+577%)

Net Assets

£2.78M

Increased by £2.20M (+379%)

Total Liabilities

£115.46k

Increased by £30.70k (+36%)

Turnover

N/A

Employees

14

Decreased by 1 (-7%)

Debt Ratio

4%

Decreased by 9 (-69%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 2

Investors (10)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2021Seed
Investor 2Apr 2021Seed
Investor 3Apr 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 22,842,933 Shares £9.89m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Nov 20259,185,727£3.10m£0.337
28 Oct 20249,185,727£3.10m£0.337
28 Oct 20241,481,588£400k£0.27
4 Nov 20222,947,370£1.40m£0.475
31 Mar 202136,873£1.75m£47.5

Officers

Officers

1 active 2 resigned
Status
Anne JonesDirectorAmericanUnited States5628 Oct 2024Active

Shareholders

Shareholders (31)

Merck Ventures B.v
19.4%
6,222,590
Bioprocess360 Lp
18.5%
5,926,276

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Philipp Braeuninger-weimer

Ceased 21 May 2018

Ceased

Ruizhi Wang

Ceased 4 Nov 2022

Ceased

Christoph Rogalla Von Bieberstein

Ceased 31 Mar 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Dec 2025Confirmation StatementConfirmation statement made on 2025-12-10 with updates
4 Dec 2025CapitalAllotment of shares (GBP 3,205.2512) on 2025-11-21
8 May 2025AccountsAnnual accounts made up to 2024-12-31
18 Dec 2024Confirmation StatementConfirmation statement made on 2024-12-10 with updates
12 Dec 2024OfficersAppointment of Anne Jones as director on 2024-10-28
29 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-12-10 with updates

4 Dec 2025 Capital

Allotment of shares (GBP 3,205.2512) on 2025-11-21

8 May 2025 Accounts

Annual accounts made up to 2024-12-31

18 Dec 2024 Confirmation Statement

Confirmation statement made on 2024-12-10 with updates

12 Dec 2024 Officers

Appointment of Anne Jones as director on 2024-10-28

Recent Activity

Latest Activity

Confirmation statement made on 2025-12-10 with updates

3 months ago on 29 Dec 2025

Allotment of shares (GBP 3,205.2512) on 2025-11-21

4 months ago on 4 Dec 2025

Annual accounts made up to 2024-12-31

11 months ago on 8 May 2025

Confirmation statement made on 2024-12-10 with updates

1 years ago on 18 Dec 2024

Appointment of Anne Jones as director on 2024-10-28

1 years ago on 12 Dec 2024